Merck & Co Inc (MRK)
89.23
+1.63
(+1.86%)
USD |
NYSE |
Mar 28, 16:00
89.15
-0.08
(-0.09%)
After-Hours: 20:00
Merck Enterprise Value: 248.88B for March 28, 2025
View 4,000+ Financial Data Types:
Add
Browse
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Amgen Inc | 213.02B |
| Gilead Sciences Inc | 154.28B |
| Johnson & Johnson | 406.63B |
| Regeneron Pharmaceuticals Inc | 62.65B |
| Moderna Inc | 5.007B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 3.743B |
| Revenue (Quarterly) | 15.62B |
| Total Expenses (Quarterly) | 11.28B |
| EPS Diluted (Quarterly) | 1.48 |
| Gross Profit Margin (Quarterly) | 75.50% |
| Profit Margin (Quarterly) | 23.96% |
| Earnings Yield | 7.54% |
| Operating Earnings Yield | 8.92% |
| Normalized Earnings Yield | 7.742 |